Development of a peroxisome proliferator-activated receptor gamma (PPARG) immunohistochemistry (IHC) assay in advanced urothelial carcinoma (UC) may provide a precision approach to patient selection for FX-909, a first-in-class PPARG-targeting agent.
FX-909
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Development of a peroxisome proliferator-activated receptor gamma (PPARG) immunohistochemistry (IHC) assay in advanced urothelial carcinoma (UC) may provide a precision approach to patient selection for FX-909, a first-in-class PPARG-targeting agent. ### Output: FX-909